Humalog (Insulin Lispro (Rdna Origin)) - Summary

HUMALOG SUMMARY

Humalog® (insulin lispro, rDNA origin) is a human insulin analog that is a rapid-acting, parenteral blood glucose-lowering agent.

Humalog is an insulin analog that is indicated in the treatment of patients with diabetes mellitus for the control of hyperglycemia. Humalog has a more rapid onset and a shorter duration of action than human regular insulin. Therefore, in patients with type 1 diabetes, Humalog should be used in regimens that include a longer-acting insulin. However, in patients with type 2 diabetes, Humalog may be used without a longer-acting insulin when used in combination therapy with sulfonylurea agents.

HUMALOG NEWS HIGHLIGHTS

Media Articles Related to Humalog (Insulin Lispro)

FDA Drug and Device Approvals: June 10, 2004
Source: Medscape Pharmacotherapy Headlines [2004.06.10]

more>>

Published Studies Related to Humalog (Insulin Lispro)

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. [2008.03.29]

A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period. [2008.02]

A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes. [2008.02]

Evaluation of the pituitary function with insulin tolerance (hypoglycaemia) testing: are there any differences using insulin lispro compared to regular insulin? [2008]

A morning dose of insulin glargine prevents nocturnal ketosis after postprandial interruption of continuous subcutaneous insulin infusion with insulin lispro. [2007.12]

more>>

Clinical Trials Related to Humalog (Insulin Lispro)

Comparison of Insulins Aspart and Lispro in Insulin Pumps [Active, not recruiting]

Lispro Mix 25 vs. Glargine in Type 2 Diabetics [Completed]

Local Registration Trial in China Humalog Mix 50 [Completed]

Lyspro Insulin vs Regular Insulin in Cirrhotic Patients [Completed]

A Clinical Trial Comparing Efficacy and Safety of Exubera and Humalog [Recruiting]

more>>